Utah
CNS clinical trials in Utah
52 CNS studies are recruiting participants at sites in 10 cities across Utah as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Utah city with a recruiting study
By research area: Depression (21), Migraine (10), Parkinson's Disease (7), Epilepsy (5), Multiple Sclerosis (4), ADHD (3), Bipolar Disorder (1), Schizophrenia (1).
Salt Lake City (32), Clinton (7), Bountiful (6), Draper (6), Orem (5), Ogden (4), Provo (4), Murray (2), Riverton (2), Logan (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Depression: recently updated in Utah
Basic details from each study's public record (the 12 most recently updated of 52). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Recruiting in
- Clinton · Salt Lake City
- Registry record
- NCT07226661 · updated
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Phase 2
- Ages 18 to 80
- All sexes
- Sponsor
- Reunion Neuroscience Inc
- Recruiting in
- Draper
- Registry record
- NCT07002034 · updated
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Definium Therapeutics US, Inc.
- Recruiting in
- Draper · Orem
- Registry record
- NCT07592689 · updated
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- University of Utah
- Recruiting in
- Salt Lake City
- Registry record
- NCT06767566 · updated
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Recruiting in
- Salt Lake City
- Registry record
- NCT07284667 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Utah on ClinicalTrials.gov.
ADHD: recently updated in Utah
The Myelin Disorders Biorepository Project
- Observational
- All ages
- All sexes
- Sponsor
- Children's Hospital of Philadelphia
- Recruiting in
- Salt Lake City
- Registry record
- NCT03047369 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Provo
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Provo
- Registry record
- NCT07717892 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Utah on ClinicalTrials.gov.
Parkinson's disease: recently updated in Utah
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Salt Lake City
- Registry record
- NCT06841354 · updated
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Murray
- Registry record
- NCT06966700 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Utah on ClinicalTrials.gov.
Migraine: recently updated in Utah
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Phase 4
- Ages 18 to 70
- All sexes
- Sponsor
- Mayo Clinic
- Recruiting in
- Ogden
- Registry record
- NCT06972056 · updated
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Recruiting in
- Salt Lake City
- Registry record
- NCT07816367 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Utah on ClinicalTrials.gov.
Ask about studies in Utah
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections